Search Results - "François Lifermann"
-
1
Adult-onset Still's disease biological treatment strategy may depend on the phenotypic dichotomy
Published in Arthritis research & therapy (12-02-2019)“…Adult-onset Still's disease (AOSD) phenotype appears to be dichotomized in systemic or chronic articular forms. As biologicals and particularly interleukin…”
Get full text
Journal Article -
2
Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)
Published in Annals of the rheumatic diseases (01-08-2018)“…To compare individually tailored, based on trimestrial biological parameter monitoring, to fixed-schedule rituximab reinfusion for remission maintenance of…”
Get more information
Journal Article -
3
Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Trial
Published in Annals of internal medicine (04-08-2020)“…Biannual rituximab infusions over 18 months effectively maintain remission after a "standard" remission induction regimen for patients with antineutrophil…”
Get full text
Journal Article -
4
Azathioprine or Methotrexate Maintenance for ANCA-Associated Vasculitis
Published in The New England journal of medicine (25-12-2008)“…Current standard therapy for Wegener's granulomatosis and microscopic polyangiitis combines corticosteroids and cyclophosphamide to induce remission, followed…”
Get full text
Journal Article -
5
Usefulness of 2‐[18F]‐fluoro‐2‐deoxy‐d‐glucose–Positron Emission Tomography/Computed Tomography for Staging and Evaluation of Treatment Response in IgG4‐Related Disease: A Retrospective Multicenter Study
Published in Arthritis care & research (2010) (01-01-2014)“…Objective To evaluate the usefulness of 2‐[18F]‐fluoro‐2‐deoxy‐d‐glucose–positron emission tomography/computed tomography (FDG‐PET/CT) in IgG4‐related disease…”
Get full text
Journal Article -
6
Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease
Published in Journal of clinical oncology (10-02-2015)“…Histiocytoses are rare disorders with heterogeneous prognosis. BRAF(V600E) mutations have been observed in half of patients with Langerhans cell histiocytosis…”
Get full text
Journal Article -
7
Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma
Published in Journal of clinical oncology (01-07-2019)“…The wide heterogeneity in multiple myeloma (MM) outcome is driven mainly by cytogenetic abnormalities. The current definition of high-risk profile is…”
Get full text
Journal Article -
8
In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present From Diagnosis in Tiny, Undetectable Subclonal Populations
Published in Journal of clinical oncology (20-03-2023)“…Multiple myeloma (MM) is characterized by copy number abnormalities (CNAs), some of which influence patient outcomes and are sometimes observed only at…”
Get full text
Journal Article -
9
Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled Trial
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-11-2017)“…In most patients with nonsevere systemic necrotizing vasculitides (SNVs), remission is achieved with glucocorticoids alone, but one-third experience a relapse…”
Get full text
Journal Article -
10
Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative Study
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-03-2021)“…Objective To describe the efficacy and safety of biologics for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA). Methods A retrospective…”
Get full text
Journal Article -
11
Improved survival in multiple myeloma during the 2005–2009 and 2010–2014 periods
Published in Leukemia (01-12-2021)Get full text
Journal Article -
12
Clinical and biological features in PIEZO1 -hereditary xerocytosis and Gardos channelopathy: a retrospective series of 126 patients
Published in Haematologica (Roma) (01-08-2019)“…We describe the clinical, hematologic and genetic characteristics of a retrospective series of 126 subjects from 64 families with hereditary xerocytosis…”
Get full text
Journal Article -
13
Retrospective Multicenter Study Comparing Infectious and Noninfectious Aortitis
Published in Clinical infectious diseases (08-02-2023)“…Abstract Background Determining the etiology of aortitis is often challenging, in particular to distinguish infectious aortitis (IA) and noninfectious aortitis…”
Get full text
Journal Article -
14
VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation
Published in Nature communications (30-01-2024)“…Acquired mutations in the UBA1 gene were recently identified in patients with severe adult-onset auto-inflammatory syndrome called VEXAS (vacuoles, E1 enzyme,…”
Get full text
Journal Article -
15
ANCA-associated scleritis: impact of ANCA on presentation, response to therapy and outcome
Published in Rheumatology (Oxford, England) (01-02-2024)“…To describe the characteristics, treatment and outcome of isolated ANCA-associated scleritis at diagnosis compared with idiopathic scleritis with negative ANCA…”
Get full text
Journal Article -
16
Tocilizumab in Giant Cell Arteritis: A Multicenter Retrospective Study of 34 Patients
Published in Journal of rheumatology (01-08-2016)“…To report the efficacy and safety of tocilizumab (TCZ) for giant cell arteritis (GCA). A retrospective multicenter study that included 34 patients receiving…”
Get full text
Journal Article -
17
Severe Viral Myopericarditis With Autoantibodies Directed Against RNA Polymerase III
Published in Annals of internal medicine (07-04-2020)“…Viruses cause most cases of acute myopericarditis. Antibodies against RNA polymerase III (RNApol3) are rare and usually associated with severe systemic…”
Get full text
Journal Article -
18
Microscopic polyangiitis: Clinical characteristics and long-term outcomes of 378 patients from the French Vasculitis Study Group Registry
Published in Journal of autoimmunity (01-08-2020)“…To describe characteristics and long-term outcomes of patients with microscopic polyangiitis (MPA), an antineutrophil cytoplasm antibody (ANCA)-associated…”
Get full text
Journal Article -
19
Granulomatosis with polyangiitis: Study of 795 patients from the French Vasculitis Study Group registry
Published in Seminars in arthritis and rheumatism (01-04-2021)“…To describe the characteristics and long-term outcomes of patients with granulomatosis with polyangiitis (GPA) from the French Vasculitis Study Group database…”
Get full text
Journal Article -
20
Plasma cell–directed therapies in monoclonal gammopathy–associated scleromyxedema
Published in Blood (02-04-2020)“…Scleromyxedema is a rare skin and systemic mucinosis that is usually associated with monoclonal gammopathy (MG). In this French multicenter retrospective study…”
Get full text
Journal Article